Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alkindo Naratama Tbk (ALDO) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Alkindo Naratama Tbk
Brigit Biofarmaka Teknologi Tbk.

Price performance

Price movement over the last 24 hours

Key statistics

Alkindo Naratama Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Alkindo Naratama Tbk trades at Rp690 (market cap 1.89T, 1.7K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 160.57B, 2.51M 24h volume). The key difference: Alkindo Naratama Tbk is far larger — about 11.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (2.51M versus 1.7K). Which is the better fit depends on your goals.

ALDOOBAT
Market Cap
1.89T160.57B
Volume
1.7K2.51M
Lot
1725.09K
Turnover
1.17M636.74M
Average Price
688.24253.78
Value
1.17M636.74M
Indicative Equilibrium Price
690242
Indicative Equilibrium Volume
1146

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ALDO
View details
OBAT
View details

About Alkindo Naratama Tbk

PT Alkindo Naratama Tbk (the "Company") was established based on Notarial Deed No 74 of Kikit Warianti SH, dated January 31, 1989. The Company's Articles of Association have been amended several times. The latest amendment was based on Notarial Deed No. 5 of Nunuy Rahmayati SH dated March 15, 2011 pertaining of Authorized share and paid-up capital, issuance of new share to be offered to the public in the Initial Public Offering, and amendment of the Article of Association of the Company to become a public entity

Read more on ALDO

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT